Asaf Danziger

Insider Reports History

Location
Tirat Hacarmel
Signature
Steven Robbins, as attorney in fact for Danziger, Asaf
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Asaf Danziger:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Director Ordinary Shares 416,474 $4,577,049 $10.99 31 Dec 2025 Direct

Insider Reports Filed by Asaf Danziger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 31 Dec 2025 1 +$10.99 5 Director 08 Jan 2026, 16:21
NVCR NovoCure Ltd 30 Jun 2025 1 +$12,603 4 Director 01 Jul 2025, 16:19
NVCR NovoCure Ltd 01 Jan 2025 2 +$6,076 4 Director 03 Jan 2025, 16:04
NVCR NovoCure Ltd 28 Jun 2024 1 +$15,165 4 Chief Executive Officer, Director 06 Aug 2024, 16:19
NVCR NovoCure Ltd 30 Jun 2023 1 +$12,948 4 Chief Executive Officer, Director 06 Jul 2023, 16:12
NVCR NovoCure Ltd 05 Jan 2023 15 -$21,476,675 4 Chief Executive Officer, Director 09 Jan 2023, 17:18
NVCR NovoCure Ltd 05 Jul 2022 1 +$16,305 4 Chief Executive Officer, Director 07 Jul 2022, 17:48
NVCR NovoCure Ltd 03 Mar 2022 1 +$1,085,547 4 Chief Executive Officer, Director 07 Mar 2022, 17:22
NVCR NovoCure Ltd 06 Jan 2022 1 +$1,978 4 Chief Executive Officer, Director 12 Jan 2022, 16:31
NVCR NovoCure Ltd 26 Nov 2021 3 +$509,539 4 Chief Executive Officer, Director 29 Nov 2021, 15:48
NVCR NovoCure Ltd 06 Jul 2021 1 +$16,180 4 Chief Executive Officer, Director 08 Jul 2021, 17:31